Zurueck zur Suche

Reporte zur Charge EK417U

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

1Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 1

VAERS 1436126

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EK417U

mild
Staat
TX
Alter
73,0
Geschlecht
F
Eingang
30.06.2021
Impfdatum
14.01.2021
Beginn
21.01.2021
Tage bis Beginn
7,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Rash Rash macular Urticaria

Symptomtext

she broke out in rash. First it was on her knuckles. It was very red almost like hives. Then in a couple of days she had this rash on her knees and went down to her ankles.; There are still a few red spots; Rash on knees, legs, down to ankles; she broke out in rash. First it was on her knuckles. It was very red almost like hives. Then in a couple of days she had this rash on her knees and went down to her ankles.; she broke out in rash. First it was on her knuckles. It was very red almost like hives. Then in a couple of days she had this rash on her knees and went down to her ankles.; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EK417U; Expiration Date: Mar2021), via an unspecified route of administration in the left arm on 14Jan2021 at 15:00 (at the age of 73-year-old) as dose 2, single for COVID-19 immunization in hospital. Medical history included ongoing diabetes mellitus, which was under control and blood pressure abnormal, lipids, blood cholesterol, herpes simplex from an unknown date and unknown if ongoing. Concomitant medications included empagliflozin, metformin hydrochloride (SYNJARDY) taken for diabetes mellitus, losartan taken for blood pressure abnormal; atorvastatin taken for lipids, blood cholesterol abnormal, colecalciferol (VITAMIN D3) taken for an unspecified indication, cyanocobalamin, folic acid (VITAMIN B12 & FOLIC ACID) taken for an unspecified indication, valaciclovir hydrochloride (VACLOVIR) to prevent the return of herpes II, all from an unspecified start date and ongoing. Historical vaccines included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EK5730; Expiration Date: Mar2021), via an unspecified route of administration in the left arm on 21Dec2021 (at the age of 73-year-old) as dose 1, single for COVID-19 immunization. No Investigation assessment was not provided. The patient did not receive any other vaccines within four weeks prior to the vaccination. No vaccines were administered on the same date of Pfizer suspect. It was reported that "Psychologist calling about the Pfizer vaccine, the Pfizer COVID vaccine". Patient wanted to bring to our attention the symptom she has experienced as well as find out if other people have reported it. She mentioned seven days after getting the second Pfizer COVID vaccine she broke out in rash. First it was on her knuckles. It was very red almost like hives. Then in a couple of days she had this rash on her knees and went down to her ankles. It was more severe on her legs. The rash remained for ten days. She had to use a lot of Cortisone Cream and Benadryl to keep it in check. She had to use these medications multiple times a day. She also saw an allergist and they could not come up with any other exposure to cause this reaction. She was wondering if anyone else had this skin reaction, seven days after the dose. The rash on her knuckles started on 21Jan2021. It lasted about ten days. She noticed it around 5pm. A couple of days later, around 23Jan2021 she started to notice the rash on her legs. The rash on her legs was more severe than the rash on her knuckles. She stated the rash on her legs that was on her knees that went to ankles is not itching anymore. There are still a few red spots, but they have mainly gone away. She does not remember the time of onset for when she noticed the rash on her knees, legs, down to ankle. She was not sure of the lot number from the second dose as she cannot make the handwriting all the way out. She provided it as EK417U and stated the last digit does not look like a number, but she cannot make it out. The adverse event resulted in physician's office visit. The outcome of rash, redness, spot-like rash was reported as resolved, rash on leg was resolving and hives was unknown. Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Diabetes (Stated it is under control)
Vorgeschichte
Medical History/Concurrent Conditions: Blood cholesterol abnormal; Blood pressure abnormal; Herpes simplex; Lipids
Andere Medikamente
SYNJARDY; LOSARTAN; ATORVASTATIN; VITAMIN D3; VITAMIN B12 & FOLIC ACID; VACLOVIR
Allergien
-
Vorherige Impfungen
-